[{"data": {"name": "The preclinical pharmacology of the high affinity anti-IL-6R Nanobody\u00ae ALX-0061 supports its clinical development in rheumatoid arthritis", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Maarten Van Roy", "@type": "Person"}, {"name": "Cedric Ververken", "@type": "Person"}, {"name": "Els Beirnaert", "@type": "Person"}, {"name": "Sven Hoefman", "@type": "Person"}, {"name": "Joost Kolkman", "@type": "Person"}, {"name": "Michel Vierboom", "@type": "Person"}, {"name": "Elia Breedveld", "@type": "Person"}, {"name": "Bert \u2018t Hart", "@type": "Person"}, {"name": "Sofie Poelmans", "@type": "Person"}, {"name": "Lieselot Bontinck", "@type": "Person"}, {"name": "Alex Hemeryck", "@type": "Person"}, {"name": "Sandy Jacobs", "@type": "Person"}, {"name": "Judith Baumeister", "@type": "Person"}, {"name": "Hans Ulrichts", "@type": "Person"}], "license": "cc-by", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://arthritis-research.biomedcentral.com/track/pdf/10.1186/s13075-015-0651-0", "encodingFormat": "application/pdf"}, {"@type": "MediaObject", "contentUrl": "http://europepmc.org/articles/pmc4476083?pdf=render", "encodingFormat": "application/pdf"}], "publisher": {"name": "Springer Science and Business Media LLC", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1186/s13075-015-0651-0", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCZswS17kFh4m-CTNTKkUjvFzaj-CD9MUcKTFYgGp-CRa8QAc5pUb9b", "propertyID": "ISCC"}], "datePublished": "2015-05-20"}, "schema": "schema.org", "mediatype": "application/ld+json"}]